[go: up one dir, main page]

ID21850A - Formula senyawa baru - Google Patents

Formula senyawa baru

Info

Publication number
ID21850A
ID21850A IDW990483A ID990483A ID21850A ID 21850 A ID21850 A ID 21850A ID W990483 A IDW990483 A ID W990483A ID 990483 A ID990483 A ID 990483A ID 21850 A ID21850 A ID 21850A
Authority
ID
Indonesia
Prior art keywords
new compound
compound formula
formula
new
compound
Prior art date
Application number
IDW990483A
Other languages
English (en)
Indonesian (id)
Inventor
Martin Bohlin
Karol Horvath
Sverker Von Unge
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20405146&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID21850(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of ID21850A publication Critical patent/ID21850A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW990483A 1996-12-20 1997-12-16 Formula senyawa baru ID21850A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9604793A SE510666C2 (sv) 1996-12-20 1996-12-20 Nya Kristallmodifikationer

Publications (1)

Publication Number Publication Date
ID21850A true ID21850A (id) 1999-08-05

Family

ID=20405146

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990483A ID21850A (id) 1996-12-20 1997-12-16 Formula senyawa baru

Country Status (36)

Country Link
US (1) US6162816A (fr)
EP (1) EP0946547B1 (fr)
JP (1) JP4402174B2 (fr)
KR (1) KR20000069595A (fr)
CN (1) CN1109684C (fr)
AR (1) AR010361A1 (fr)
AT (1) ATE236898T1 (fr)
AU (1) AU730129B2 (fr)
BR (1) BR9714059A (fr)
CA (1) CA2274076C (fr)
CZ (1) CZ294784B6 (fr)
DE (1) DE69720774T2 (fr)
DK (1) DK0946547T3 (fr)
EE (1) EE03923B1 (fr)
EG (1) EG24414A (fr)
ES (1) ES2194231T3 (fr)
HU (1) HU227589B1 (fr)
ID (1) ID21850A (fr)
IL (1) IL130450A0 (fr)
IS (1) IS1981B (fr)
MY (1) MY117032A (fr)
NO (1) NO317191B1 (fr)
NZ (1) NZ336024A (fr)
PL (1) PL190377B1 (fr)
PT (1) PT946547E (fr)
RS (1) RS49685B (fr)
RU (1) RU2184734C2 (fr)
SA (1) SA97180739B1 (fr)
SE (1) SE510666C2 (fr)
SI (1) SI0946547T1 (fr)
SK (1) SK285151B6 (fr)
TR (1) TR199901410T2 (fr)
TW (1) TW538039B (fr)
UA (1) UA55436C2 (fr)
WO (1) WO1998028294A1 (fr)
ZA (1) ZA9711046B (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SI20019A (sl) 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
UA72748C2 (en) * 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
JP3926936B2 (ja) 1998-11-16 2007-06-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホキシド誘導体・アセトン錯体およびその製造法
SE9804003D0 (sv) 1998-11-23 1998-11-23 Astra Ab A method of producing drug particles
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
JP2000344739A (ja) * 1999-06-01 2000-12-12 Sumitomo Chem Co Ltd N−保護−アゼチジン−2−カルボン酸の製造方法
TWI289557B (en) 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
ES2521690T3 (es) 2000-05-15 2014-11-13 Takeda Pharmaceutical Company Limited Procedimiento para producir un cristal de (R)-2-[[[3-metil-4-(2,2,2-trifluoroetoxi)-2-piridil]metil]sulfinil]-bencimidazol
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
WO2002012225A1 (fr) 2000-08-04 2002-02-14 Takeda Chemical Industries, Ltd. Sels de composé à base de benzimidazole et leurs applications
SI20875A (sl) * 2001-04-25 2002-10-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristalna oblika omeprazola
EP2260837A1 (fr) 2001-06-01 2010-12-15 Pozen, Inc. Compositions pharmaceutiques pour l'administration coordonnée d'AINS
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
GB2376231A (en) 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
EP1515963B1 (fr) * 2002-06-27 2007-02-14 Dr. Reddy's Laboratories Ltd. Procede de preparation de composes sulfoxyde optiquement purs ou optiquement enrichis, notamment de l'esomeprazole amorphe et ses sels
CA2491118A1 (fr) * 2002-06-27 2004-01-08 Dr. Reddy's Laboratories Limited Procede de preparation de composes sulfoxyde optiquement purs ou optiquement enrichis, notamment de l'esomeprazole amorphe et ses sels
CA2501424A1 (fr) * 2002-08-30 2004-03-11 Dr. Reddy's Laboratories Limited Hydrates amorphes d'esomeprazole magnesium et leur procede de preparation
AU2003273000A1 (en) 2002-10-16 2004-05-04 Takeda Pharmaceutical Company Limited Stable solid preparations
CN1728997A (zh) * 2002-10-22 2006-02-01 兰贝克赛实验室有限公司 (es)奥美拉唑的无定形盐
WO2004046134A2 (fr) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Composes d'esomeprazole cristallins et procede permettant de preparer ces composes
BRPI0407906A (pt) * 2003-02-28 2006-02-14 Ranbaxy Lab Ltd polimorfos de s-omeprazol
EP1607395B1 (fr) 2003-03-24 2011-05-04 Eisai R&D Management Co., Ltd. Procédé de préparation de sel de sodium de rabeprazole amorphe
WO2004099181A1 (fr) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Sel de baryum d'un derive de benzimidazole
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE0400410D0 (sv) 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2570916C (fr) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Forme posologique d'ipp a doses multiples
CN103772360A (zh) * 2004-06-24 2014-05-07 阿斯利康(瑞典)有限公司 制备用于制备艾美拉唑钠盐的结晶修饰物的新方法
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
US20090298884A1 (en) * 2005-05-06 2009-12-03 Glenmark Generics Ltd. Esomeprazole Strontium Salt, Process For Its Preparation and Pharmaceutical Compositions Containing Same
EP1907375B1 (fr) * 2005-06-08 2013-07-24 LEK Pharmaceuticals d.d. Solvate cristallin de sodium d'omeprazole
EP1891043A1 (fr) 2005-06-15 2008-02-27 Hetero Drugs Limited Ésoméprazole hydraté amorphe
NL2000126C2 (nl) * 2005-07-15 2008-01-29 Solvay Werkwijze voor de vervaardiging van eptifibatide.
US20070043085A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of amorphous form of neutral esomeprazole
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
WO2007054951A1 (fr) * 2005-11-14 2007-05-18 Hetero Drugs Limited Procédé d'obtention d’ésoméprazole amorphe
US8124779B2 (en) * 2005-12-05 2012-02-28 Astrazeneca Ab Process for the preparation of esomeprazole non-salt form
EP1801110A1 (fr) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Sel d'arginine d'ésoméprazole
KR101289215B1 (ko) 2005-12-28 2013-07-29 유니온 퀴미코 파르마세우티카, 에스.에이. 오메프라졸의 (에스)-엔안티오머의 제조 방법
EP2000468A1 (fr) * 2007-05-09 2008-12-10 Dr. Reddy's Laboratories Ltd. Sels d'ésoméprazole et procédés pour leur préparation
EP2195309A4 (fr) 2007-10-08 2013-04-24 Hetero Drugs Ltd Polymorphes de sels de l'ésoméprazole
MX2010009641A (es) 2008-03-10 2010-09-22 Takeda Pharmaceutical Cristal de compuestos de bencimidazol.
EP2143722A1 (fr) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Procédé de préparation de sodium ésoméprazole de haute pureté chimique et nouvelles formes de sodium ésoméprazole
CN102209529A (zh) 2008-09-09 2011-10-05 阿斯利康(瑞典)有限公司 将药物组合物递送至有需要的患者的方法
JP2012531409A (ja) 2009-06-25 2012-12-10 アストラゼネカ・アクチエボラーグ Nsaid関連潰瘍を発症するリスクがある患者の処置方法
SG181535A1 (en) 2009-12-08 2012-07-30 Codexis Inc Synthesis of prazole compounds
WO2012078800A2 (fr) 2010-12-08 2012-06-14 Codexis, Inc. Biocatalyseurs et procédés de synthèse de l'armodafinil
EA028049B1 (ru) 2011-12-28 2017-10-31 Поузен Инк. Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
RU2501549C1 (ru) 2012-08-30 2013-12-20 Авва Девелопмент Лтд Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни
CN107043367A (zh) * 2017-05-26 2017-08-15 重庆莱美隆宇药业有限公司 一种中性s‑奥美拉唑的干燥工艺
WO2024075017A1 (fr) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition de calcification de valve aortique

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US5877192A (en) * 1993-05-28 1999-03-02 Astra Aktiebolag Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
ATE206044T1 (de) * 1994-07-08 2001-10-15 Astrazeneca Ab Aus mehreren einzeleinheiten zusammengesetzte dosierungsform in tablettenform (i)

Also Published As

Publication number Publication date
BR9714059A (pt) 2000-05-09
IS5070A (is) 1999-06-07
ATE236898T1 (de) 2003-04-15
PT946547E (pt) 2003-07-31
RS49685B (sr) 2007-11-15
IL130450A0 (en) 2000-06-01
CZ220299A3 (cs) 2000-02-16
EE03923B1 (et) 2002-12-16
NO993068L (no) 1999-06-21
YU28199A (sh) 2002-03-18
KR20000069595A (ko) 2000-11-25
HUP0001547A3 (en) 2002-06-28
NZ336024A (en) 2001-02-23
HK1022909A1 (en) 2000-08-25
PL190377B1 (pl) 2005-12-30
TW538039B (en) 2003-06-21
SE510666C2 (sv) 1999-06-14
SE9604793L (sv) 1998-06-21
WO1998028294A1 (fr) 1998-07-02
DE69720774D1 (de) 2003-05-15
IS1981B (is) 2005-01-14
AU5502698A (en) 1998-07-17
CN1241183A (zh) 2000-01-12
SE9604793D0 (sv) 1996-12-20
MY117032A (en) 2004-04-30
EG24414A (en) 2009-05-25
RU2184734C2 (ru) 2002-07-10
CZ294784B6 (cs) 2005-03-16
NO993068D0 (no) 1999-06-21
HU0001547D0 (fr) 2002-05-29
HUP0001547A2 (hu) 2002-05-29
HU227589B1 (en) 2011-09-28
ZA9711046B (en) 1998-06-22
EP0946547B1 (fr) 2003-04-09
AR010361A1 (es) 2000-06-07
SK76599A3 (en) 1999-12-10
UA55436C2 (uk) 2003-04-15
SA97180739B1 (ar) 2006-05-20
ES2194231T3 (es) 2003-11-16
EE9900259A (et) 2000-02-15
DK0946547T3 (da) 2003-06-30
TR199901410T2 (xx) 1999-08-23
SI0946547T1 (en) 2003-10-31
CN1109684C (zh) 2003-05-28
DE69720774T2 (de) 2004-02-05
AU730129B2 (en) 2001-02-22
PL334297A1 (en) 2000-02-14
CA2274076C (fr) 2008-09-30
SK285151B6 (sk) 2006-07-07
CA2274076A1 (fr) 1998-07-02
US6162816A (en) 2000-12-19
NO317191B1 (no) 2004-09-13
JP2001507025A (ja) 2001-05-29
EP0946547A1 (fr) 1999-10-06
JP4402174B2 (ja) 2010-01-20

Similar Documents

Publication Publication Date Title
ID21850A (id) Formula senyawa baru
ID19430A (id) Senyawa senyawa heterosiklik
BR9709230A (pt) Composto
ID16660A (id) Senyawa-senyawa b-laktam monosiklik baru
ID19609A (id) Senyawa-senyawa heterosiklik
ID19403A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
ID21881A (id) Turunan-turunan baru pirazol tersubstitusi
BR9509760A (pt) Composto
ID15904A (id) Senyawa-senyawa tiofenopirimidina
BR9707051A (pt) Composto
ID19476A (id) Senyawa piridilpirol
ID18685A (id) Senyawa trisiklik tersubstitusi
DE69716924D1 (de) Phosphonat-nukleotid-verbindungen
ID18431A (id) Senyawa-senyawa baru
BR9705635A (pt) Compostos
BR9711205A (pt) Composto
DK0923594T3 (da) Bromotiacumicinforbindelser
ID19433A (id) Senyaw-senyawa baru
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
ID16684A (id) Senyawa-senyawa sulfonilurea baru
ID18889A (id) Senyawa baru
ID22144A (id) Senyawa-senyawa baru
BR9509740A (pt) Compostos 18-nor-vitamina d
ID16373A (id) Senyawa-senyawa baru